The Magazine for Sleep Professionals
Wednesday, September 9, 2026
When it comes to pediatric sleep studies, transcutaneous monitoring plays a crucial role in providing optimal care for young patients. At the Nemours Children’s Hospital Pediatric Sleep Center in Orlando, Florida, CO2 monitoring is integrated into therapist-driven protocols to ensure accurate diagnosis and optimal management of sleep-disordered breathing for pediatric […]
EnsoData, a leader in healthcare AI technology, is partnering with Advanced Brain Monitoring (ABM) to add position data captured by ABM’s Night Shift sleep positioner into the FDA-cleared EnsoSleep PPG home sleep test (HST). Adding positional data to EnsoSleep PPG offers providers accurate supine AHI severity insights, leading to better […]
EnsoData, an innovator in AI healthtech solutions, is proud to introduce a new RPM (remote physiological monitoring) offering to the EnsoSleep PPG ecosystem of AI tools. EnsoData’s RPM solution allows clinicians to seamlessly monitor patients over time and proactively intervene when patients need support with their therapy the most. RPM […]
Similar to its prevalence in the adult population, obstructive sleep apnea (OSA) in children is one of the most common manifestations of sleep-related breathing disorders. The prevalence of OSA in children has significantly increased in the last 20 years, particularly among the younger population, possibly linked to the rise in […]
In a new study published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine, researchers examined whether sleep disordered breathing (primarily obstructive sleep apnea) during pregnancy and in the years after delivery is associated with an increased risk for hypertension and metabolic syndrome. Metabolic syndrome consists […]
Signifier Medical Technologies (“Signifier”) has closed a circa $10M Series C funding round led by Alan Howard, VC investor and co-founder of Brevan Howard. The proceeds from this latest successful fundraising will allow Signifier to invest further in its innovative and non-invasive solutions for patients with sleep-disordered breathing conditions. The […]
Senior appointment in the US paves the way for the creation of USA operations in preparation for commercialization of eXciteOSA® and Snoozeal®, novel, non-invasive, daytime therapies for sleep-disordered breathing conditions Signifier Medical Technologies (“Signifier”), an innovator in the sleep-disordered breathing market, is pleased to announce the appointment of Philip Hess as […]
The ATS Foundation has announced its new ATS Foundation/ResMed Research Fellowship in Sleep-disordered Breathing and PAP Therapy. The award will provide funding for two years in the amount of $100,000, provided by ResMed, a global leader in connected health with more than 4 million cloud-connected PAP devices monitoring patients every […]
The U.S. Army Civilian Dental Corps and the U.S. Army Medical Command (MEDCOM), Dental Directorate are highlighting their joint advancements in dental sleep medicine, a field of dental practice that focuses on the use of oral appliance therapy to treat sleep-disordered breathing, including snoring and obstructive sleep apnea, as defined […]
